Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$2.5 - $5.19 $15,500 - $32,178
-6,200 Reduced 29.25%
15,000 $38,000
Q3 2021

Oct 20, 2021

BUY
$4.82 - $8.46 $4,820 - $8,460
1,000 Added 4.95%
21,200 $109,000
Q1 2021

Apr 19, 2021

SELL
$7.45 - $12.32 $891,020 - $1.47 Million
-119,600 Reduced 85.55%
20,200 $176,000
Q4 2020

Jan 12, 2021

BUY
$10.34 - $13.77 $221,276 - $294,678
21,400 Added 18.07%
139,800 $1.52 Million
Q3 2020

Oct 13, 2020

BUY
$11.73 - $16.25 $232,254 - $321,750
19,800 Added 20.08%
118,400 $1.41 Million
Q2 2020

Jul 16, 2020

BUY
$13.68 - $20.46 $562,248 - $840,906
41,100 Added 71.48%
98,600 $1.58 Million
Q1 2020

Apr 23, 2020

BUY
$14.83 - $26.72 $532,397 - $959,248
35,900 Added 166.2%
57,500 $892,000
Q4 2019

Jan 29, 2020

BUY
$9.77 - $24.6 $211,032 - $531,360
21,600 New
21,600 $531,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.